secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cocrystal Pharma, Inc. (COCP)
CIK:        0001412486
Form:       8-K
Filed at:   2026-03-13T23:59:59+00:00
Accession:  0001493152-26-010071
Event type: leadership
Sentiment:  negative
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cocrystal Pharma board member Dr. Anthony Japour passes away on March 10, 2026
------------------------------------------------------------------------------

- Dr. Anthony Japour, a member of Cocrystal Pharma's board of directors, died on March 10, 2026.
- The company reported the sad event in a Form 8-K filed March 13, 2026.
- No replacement or further board changes announced as of the filing date.
- Dr. Japour's passing reduces the board size; no other details provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412486/000149315226010071/0001493152-26-010071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412486/000149315226010071/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-010071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer